Related Experiment Videos
n-3 polyunsaturated fatty acids and coronary thrombosis
S D Kristensen1, A M Iversen, E B Schmidt
1Department of Cardiology, Skejby Hospital, Aarhus N, Denmark. steendk@dadlnet.dk
Lipids
|February 12, 2002
Summary
Marine n-3 fatty acids show minimal antithrombotic effects at practical doses, despite early suggestions of preventing coronary thrombosis. Their primary benefit for heart health may stem from antiarrhythmic properties rather than preventing blood clots.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Thrombosis Studies
Background:
- Early studies on Greenland Eskimos suggested high marine n-3 fatty acid intake inhibited platelet reactivity, potentially preventing coronary thrombosis.
- Subsequent research with lower, practical doses confirmed a marginal platelet inhibitory effect of n-3 fatty acids.
Purpose of the Study:
- To evaluate the antithrombotic potential of n-3 fatty acids, particularly at practical dietary intake levels.
- To assess the impact of n-3 fatty acids on platelet reactivity, blood coagulability, and fibrinolysis in relation to coronary thrombosis.
Main Methods:
- Review of studies on Greenland Eskimos and their high marine n-3 fatty acid intake.
- Analysis of clinical trials and animal models investigating the effects of various doses of n-3 fatty acids.
- Examination of n-3 fatty acid impact on platelet aggregation, blood coagulation parameters, and fibrinolytic activity.
Main Results:
- High doses of n-3 fatty acids showed significant platelet inhibition, but practical doses yielded only marginal effects.
- n-3 fatty acids demonstrated minimal impact on blood coagulability and a slight decrease in fibrinolysis.
- Animal models showed thrombosis inhibition at very high doses, while human trials with low doses showed little effect on myocardial infarction incidence.
Conclusions:
- There is limited evidence supporting a significant antithrombotic effect of practical n-3 fatty acid doses on coronary thrombosis.
- The beneficial effects of n-3 fatty acids on coronary heart disease may be primarily antiarrhythmic, not antithrombotic.